The world of science is facing a tough challenge. Noubar Afeyan, a key figure in the biotech industry, warns that the attacks on science won't stop at mRNA vaccines. He believes this trend will spread to all areas of medicine. Afeyan, who co-founded Moderna, has seen firsthand how political decisions can disrupt scientific progress. Last year, the Trump administrati...
In the fast-paced world of biotech, big names are making headlines. Pfizer's CEO, Albert Bourla, recently praised President Trump's Operation Warp Speed, even suggesting he might deserve a Nobel Prize. Meanwhile, Atlas Venture has raised a massive $400 million fund, but only a select few startups will get a chance to benefit from it. Agios Pharmaceuticals is facing ...
The idea of living longer and healthier is no longer just a dream. It's becoming a reality, thanks to the science of longevity. This field is getting serious attention from big investors like Jeff Bezos and Mark Zuckerberg. It's like the crypto world, where new ideas can change everything. LongeVC is a venture fund that invests in longevity biotech. Their first fund...
Military personnel with biotechnological enhancements face a unique set of challenges when they return to civilian life. These enhancements, designed to boost performance, can create complications when it's time to reverse them. The process of removing or modifying these enhancements is just as experimental and risky as the initial implementation. Consider the impli...
In June, family offices, which manage wealth for the ultra-rich, stepped up their investment game. They made 60 direct investments in companies, a jump from May's 47 deals. However, this is still a 40% drop compared to last year. Despite the overall decline, biotech and healthcare were hot topics, with nine deals in these sectors. One standout investment was in Anth...
In the world of biofuel production, breaking down plant material is a big challenge. Scientists have been working on ways to make this process more efficient. One promising approach involves using enzymes from a heat-loving fungus called Rasamsonia emersonii. This fungus naturally produces enzymes that can break down plant material, but not enough of a crucial type ...
A major shift is happening in the world of genetic data. Regeneron, a big name in biotechnology, is stepping in to buy 23andMe, a company known for its DNA testing kits. The price tag? A cool $256 million. This move comes as 23andMe faces bankruptcy, but Regeneron has plans to keep the company running smoothly. They want to honor the privacy promises made to 23andMe'...
Allium vegetables, like garlic and onions, pack a punch with their sulfur-rich compounds. These organosulfur compounds, or OSC's, offer a range of health benefits. They can fight cancer, reduce inflammation, manage diabetes, boost immunity, and protect the heart. These compounds are also responsible for the strong flavors and aromas that make allium vegetables so po...
The partner of a once-celebrated Silicon Valley figure has secured significant funding for a new biotech venture. This startup, Haemanthus, aims to revolutionize medical testing using artificial intelligence. The name Haemanthus is inspired by the Greek word for "blood flower, " hinting at its focus on blood-related technologies. The individual behind this new endea...
The cat family has a lot of interesting things going on with their hormones. Anti-Mullerian hormone (AMH) is one of them. It's part of a bigger group of hormones called transforming growth factor-β (TGF-β). This hormone is made by certain cells in both male and female cats. It's been studied a lot in humans, rats, and farm animals. But what about cats? Scientists st...